Scientists are finally figuring out how much dark matter — the almost imperceptible material said to tug on everything, yet emit no light — really weighs.
Hughes-Fulford launched on the STS-40 space shuttle mission in June 1991.
The first American woman to launch into space who was not a professional astronaut but a working scientist, Millie Hughes-Fulford, has died at the age of 75.
Cybercriminals are preying on emotions of fear to spread dangerous viruses and spyware across Twitter, new research has revealed.
Harvard’s Capasso Group has scaled up the achromatic metalens to 2mm in diameter. That may not sound like much, but it is plenty for virtual reality contact lenses. The human pupil is 7mm at widest. These guys are going to beat Mojo Lens to the finish line for smart contact lenses.
Read the latest updates on coronavirus from Harvard University. For SEAS specific-updates, please visit SEAS & FAS Division of Science: Coronavirus FAQs.
Though the Earth’s deeper layers have been raging at thousands of degrees for billions of years, new research involving Florida Tech has shown that tapping into that heat to produce geothermal heating for urban regions on the surface has a far, far shorter lifespan.
In the days following the Jan. 6 riot at the nation’s Capitol, there was a rush to identify those who had stormed the building’s hallowed halls.
Biochemical changes after going to space suggest that harm to cells’ energy-producing structures, called mitochondria, could explain astronauts’ health issues.
Jared Isaacman invites you to join the fight against childhood cancer, and possibly wind up with a seat on the first orbital flight by an all-civilian team of astronauts.
Catch up on your favourite BBC radio show from your favourite DJ right here, whenever you like. Listen without limits with BBC Sounds.
Research into a new drug that primes the immune system in the respiratory tract and is in development for COVID-19 shows it is also effective against rhinovirus.
Rhinovirus is the most common respiratory virus, the main cause of the common cold and is responsible for exacerbations of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease. In a study recently published in the European Respiratory Journal, the drug, known as INNA-X, is shown to be effective in a pre-clinical infection model and in human airway cells.
Treatment with INNA-X prior to infection with rhinovirus significantly reduced viral load and inhibited harmful inflammation.